Key facts
- This page summarizes David A. Ricks's Form 4 filing for ELI LILLY & Co (LLY).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 04 Nov 2026, 16:17.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Gift
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
The amount reported includes (i) 4,990 shares of Eli Lilly and Company common stock transferred to the reporting person on May 14, 2026 as an annuity payment from the 2022 GRAT and (ii) 2,111 shares of Eli Lilly and Company common stock transferred to the reporting person on September 18, 2026 as an annuity payment from the 2025 GRAT, each a Grantor Retained Annuity Trust of which the reporting person is the trustee and each paid in accordance with its terms.
Footnote F2
The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Footnote F3
On September 18, 2026, 2,111 shares of Eli Lilly and Company common stock were transferred to the reporting person as an annuity payment in accordance with the terms of the Grantor Retained Annuity Trust, of which the reporting person is the trustee.
Footnote F4
On May 14, 2026, 4,990 shares of Eli Lilly and Company common stock were transferred to the reporting person as an annuity payment in accordance with the terms of the Grantor Retained Annuity Trust, of which the reporting person is the trustee.